Last update 08 May 2025

EverNov Medicines (Zhuhai Hengqin) Limited

Private Company|2019|Guangdong Sheng, China

Overview

Related

1
Drugs associated with EverNov Medicines (Zhuhai Hengqin) Limited
EVER-4010001
Target
FGFR4
Mechanism
FGFR4 antagonists
Active Org.-
Originator Org.
EverNov Medicines (Zhuhai Hengqin) Co. Ltd.
Active Indication-
Inactive Indication
Advanced Malignant Solid Neoplasm
Drug Highest PhaseSuspended
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with EverNov Medicines (Zhuhai Hengqin) Limited
CTR20200590
/ SuspendedPhase 1/2
EVER4010001联合帕博利珠单抗用于晚期实体瘤患者中剂量递增和选定适应症的I/II期研究
[Translation] A Phase I/II Study of EVER4010001 in Combination with Pembrolizumab for Dose Escalation and Select Indications in Patients with Advanced Solid Tumors
100 Clinical Results associated with EverNov Medicines (Zhuhai Hengqin) Limited
Login to view more data
0 Patents (Medical) associated with EverNov Medicines (Zhuhai Hengqin) Limited
Login to view more data
100 Deals associated with EverNov Medicines (Zhuhai Hengqin) Limited
Login to view more data
100 Translational Medicine associated with EverNov Medicines (Zhuhai Hengqin) Limited
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 30 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
EVER-4010001
 ( FGFR4 )		Advanced Malignant Solid Neoplasm
More
Suspended
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free